Fulcrum Therapeutics Inc (FULC) — Cash Flow Quality Index
Latest as of June 2024:
1.06x
Fulcrum Therapeutics Inc (FULC) has a Cash Flow Quality Index of 1.06x as of June 2024. Operating cash flow of $58.90 Million exceeds net income of $55.41 Million, indicating high earnings quality where cash backs reported profits. Explore Fulcrum Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
1.06x
Operating CF / Net Income
Operating Cash Flow
$58.90 Million
USD
Net Income
$55.41 Million
USD
Data as of
Jun 2024
Most recent filing
Annual Cash Flow Quality Index for Fulcrum Therapeutics Inc (None–None)
Year-by-year earnings quality comparison for Fulcrum Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.